Genpact Ebitda vs Other Operating Expenses Analysis

G Stock

USD 30.90 0.21 0.68%

Genpact financial indicator trend analysis is much more than just examining Genpact Limited latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genpact Limited is a good investment. Please check the relationship between Genpact Ebitda and its Other Operating Expenses accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Ebitda vs Other Operating Expenses

Ebitda vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genpact Limited Ebitda account and Other Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Genpact's Ebitda and Other Operating Expenses is 0.98. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Genpact Limited, assuming nothing else is changed. The correlation between historical values of Genpact's Ebitda and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Genpact Limited are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Ebitda i.e., Genpact's Ebitda and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ebitda

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Genpact Limited. It is also known as Genpact overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

The Genpact's current Sales General And Administrative To Revenue is estimated to increase to 0.26, while Selling General Administrative is projected to decrease to roughly 576 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.5B	1.6B	902.8M
Total Revenue	4.0B	4.4B	4.5B	2.4B

Gross Profit Total Revenue

Genpact fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory
Total Assets		0.94	0.86	0.65	0.85	0.44	0.85	0.34	0.93	0.98	0.97	0.95	0.98	0.95	0.67	0.84	0.91	0.52	0.97	0.86	0.87	0.96	0.99	-0.72	0.91	0.01
Total Stockholder Equity	0.94		0.7	0.76	0.83	0.19	0.83	0.48	0.96	0.87	0.96	0.79	0.91	0.91	0.77	0.71	0.79	0.52	0.87	0.8	0.67	0.93	0.9	-0.8	0.74	-0.09
Net Debt	0.86	0.7		0.6	0.55	0.5	0.56	0.01	0.7	0.9	0.75	0.93	0.89	0.83	0.32	0.87	0.8	0.47	0.92	0.79	0.89	0.84	0.9	-0.44	0.91	-0.07
Retained Earnings	0.65	0.76	0.6		0.53	-0.09	0.55	0.18	0.63	0.57	0.63	0.52	0.64	0.67	0.53	0.6	0.57	0.42	0.66	0.58	0.36	0.67	0.64	-0.43	0.46	-0.54
Cash	0.85	0.83	0.55	0.53		0.39	1.0	0.52	0.83	0.82	0.9	0.75	0.79	0.77	0.81	0.63	0.86	0.32	0.75	0.64	0.7	0.72	0.79	-0.72	0.75	0.16
Other Assets	0.44	0.19	0.5	-0.09	0.39		0.38	-0.16	0.2	0.56	0.32	0.62	0.47	0.42	0.09	0.59	0.57	0.0	0.53	0.35	0.62	0.29	0.47	-0.04	0.62	0.23
Cash And Short Term Investments	0.85	0.83	0.56	0.55	1.0	0.38		0.52	0.83	0.81	0.9	0.75	0.79	0.77	0.81	0.63	0.86	0.33	0.75	0.64	0.7	0.72	0.79	-0.72	0.75	0.14
Common Stock Shares Outstanding	0.34	0.48	0.01	0.18	0.52	-0.16	0.52		0.59	0.25	0.5	0.11	0.25	0.17	0.74	0.02	0.18	0.14	0.12	0.1	0.18	0.25	0.21	-0.88	0.18	0.49
Other Stockholder Equity	0.93	0.96	0.7	0.63	0.83	0.2	0.83	0.59		0.88	0.98	0.8	0.91	0.86	0.74	0.63	0.79	0.53	0.82	0.82	0.75	0.92	0.89	-0.89	0.78	0.11
Total Liab	0.98	0.87	0.9	0.57	0.82	0.56	0.81	0.25	0.88		0.93	0.99	0.98	0.93	0.59	0.87	0.93	0.5	0.98	0.86	0.93	0.93	0.98	-0.64	0.97	0.07
Total Current Assets	0.97	0.96	0.75	0.63	0.9	0.32	0.9	0.5	0.98	0.93		0.87	0.94	0.9	0.76	0.72	0.88	0.51	0.89	0.84	0.81	0.94	0.94	-0.82	0.85	0.11
Short Long Term Debt Total	0.95	0.79	0.93	0.52	0.75	0.62	0.75	0.11	0.8	0.99	0.87		0.96	0.9	0.48	0.9	0.92	0.47	0.98	0.84	0.95	0.9	0.97	-0.52	0.98	0.05
Other Current Liab	0.98	0.91	0.89	0.64	0.79	0.47	0.79	0.25	0.91	0.98	0.94	0.96		0.95	0.55	0.83	0.9	0.51	0.97	0.91	0.89	0.97	0.99	-0.66	0.92	-0.02
Total Current Liabilities	0.95	0.91	0.83	0.67	0.77	0.42	0.77	0.17	0.86	0.93	0.9	0.9	0.95		0.57	0.78	0.85	0.57	0.95	0.91	0.76	0.93	0.97	-0.59	0.8	-0.15
Other Liab	0.67	0.77	0.32	0.53	0.81	0.09	0.81	0.74	0.74	0.59	0.76	0.48	0.55	0.57		0.46	0.56	0.38	0.53	0.39	0.4	0.55	0.57	-0.79	0.5	0.17
Property Plant And Equipment Net	0.84	0.71	0.87	0.6	0.63	0.59	0.63	0.02	0.63	0.87	0.72	0.9	0.83	0.78	0.46		0.8	0.29	0.92	0.62	0.8	0.77	0.84	-0.36	0.89	-0.14
Current Deferred Revenue	0.91	0.79	0.8	0.57	0.86	0.57	0.86	0.18	0.79	0.93	0.88	0.92	0.9	0.85	0.56	0.8		0.38	0.9	0.84	0.87	0.84	0.9	-0.52	0.91	0.0
Accounts Payable	0.52	0.52	0.47	0.42	0.32	0.0	0.33	0.14	0.53	0.5	0.51	0.47	0.51	0.57	0.38	0.29	0.38		0.5	0.62	0.4	0.58	0.57	-0.4	0.41	-0.23
Non Current Assets Total	0.97	0.87	0.92	0.66	0.75	0.53	0.75	0.12	0.82	0.98	0.89	0.98	0.97	0.95	0.53	0.92	0.9	0.5		0.86	0.87	0.94	0.98	-0.53	0.93	-0.11
Non Currrent Assets Other	0.86	0.8	0.79	0.58	0.64	0.35	0.64	0.1	0.82	0.86	0.84	0.84	0.91	0.91	0.39	0.62	0.84	0.62	0.86		0.76	0.91	0.91	-0.54	0.76	-0.17
Long Term Debt	0.87	0.67	0.89	0.36	0.7	0.62	0.7	0.18	0.75	0.93	0.81	0.95	0.89	0.76	0.4	0.8	0.87	0.4	0.87	0.76		0.82	0.88	-0.53	0.98	0.25
Net Receivables	0.96	0.93	0.84	0.67	0.72	0.29	0.72	0.25	0.92	0.93	0.94	0.9	0.97	0.93	0.55	0.77	0.84	0.58	0.94	0.91	0.82		0.97	-0.66	0.85	-0.08
Good Will	0.99	0.9	0.9	0.64	0.79	0.47	0.79	0.21	0.89	0.98	0.94	0.97	0.99	0.97	0.57	0.84	0.9	0.57	0.98	0.91	0.88	0.97		-0.63	0.92	-0.05
Common Stock Total Equity	-0.72	-0.8	-0.44	-0.43	-0.72	-0.04	-0.72	-0.88	-0.89	-0.64	-0.82	-0.52	-0.66	-0.59	-0.79	-0.36	-0.52	-0.4	-0.53	-0.54	-0.53	-0.66	-0.63		-0.54	-0.34
Non Current Liabilities Total	0.91	0.74	0.91	0.46	0.75	0.62	0.75	0.18	0.78	0.97	0.85	0.98	0.92	0.8	0.5	0.89	0.91	0.41	0.93	0.76	0.98	0.85	0.92	-0.54		0.15
Inventory	0.01	-0.09	-0.07	-0.54	0.16	0.23	0.14	0.49	0.11	0.07	0.11	0.05	-0.02	-0.15	0.17	-0.14	0.0	-0.23	-0.11	-0.17	0.25	-0.08	-0.05	-0.34	0.15

Click cells to compare fundamentals

Genpact Account Relationship Matchups

Genpact fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.5B	4.9B	5.0B	4.6B	4.8B	3.1B
Total Stockholder Equity	1.7B	1.8B	1.9B	1.8B	2.2B	1.4B
Net Debt	1.3B	1.3B	1.1B	1.0B	919.3M	965.3M
Retained Earnings	648.7M	741.7M	732.5M	780.0M	1.1B	1.1B
Cash	467.1M	680.4M	899.5M	646.8M	583.7M	449.6M
Other Assets	478.8M	961.1M	667.3M	439.6M	1.0	0.95
Cash And Short Term Investments	467.1M	680.4M	899.5M	646.8M	583.7M	472.7M
Common Stock Shares Outstanding	195.2M	195.8M	193.0M	188.1M	185.1M	200.1M
Liabilities And Stockholders Equity	4.5B	4.9B	5.0B	4.6B	4.8B	3.1B
Other Stockholder Equity	1.6B	1.6B	1.7B	1.8B	1.9B	1.3B
Total Liab	2.8B	3.0B	3.1B	2.8B	2.6B	1.6B
Total Current Assets	1.6B	1.7B	1.9B	1.8B	1.9B	1.2B
Short Long Term Debt Total	1.8B	1.9B	2.0B	1.7B	1.5B	950.6M
Other Current Liab	629.7M	694.0M	678.2M	675.7M	674.4M	470.9M
Total Current Liabilities	910.2M	1.2B	1.3B	1.1B	1.3B	758.6M
Other Liab	192.2M	239.9M	249.2M	208.0M	239.2M	192.5M
Property Plant And Equipment Net	584.9M	535.8M	485.7M	379.1M	393.7M	285.6M
Current Deferred Revenue	97.3M	154.7M	160.6M	160.6M	112.4M	77.9M
Accounts Payable	22.0M	13.9M	25.0M	35.8M	27.7M	20.2M
Non Current Assets Total	2.9B	3.1B	3.1B	2.8B	2.9B	1.9B
Non Currrent Assets Other	217.1M	323.8M	322.2M	450.5M	379.6M	213.0M
Long Term Debt	1.3B	1.3B	1.3B	1.2B	824.7M	690.1M
Net Receivables	914.3M	881.0M	887.7M	994.8M	1.1B	613.1M
Good Will	1.6B	1.7B	1.7B	1.7B	1.7B	1.2B
Common Stock Total Equity	1.9M	1.9M	1.8M	1.8M	1.6M	2.6M
Non Current Liabilities Total	1.9B	1.8B	1.8B	1.7B	1.2B	966.8M
Inventory	121.2M	150.1M	103.7M	1.0	1.15	1.09
Other Current Assets	49.2M	37.3M	30.7M	138.0M	169.0M	177.5M
Property Plant And Equipment Gross	618.4M	585.9M	485.7M	379.1M	984.1M	1.0B
Accumulated Other Comprehensive Income	(532.0M)	(545.3M)	(554.4M)	(733.1M)	(722.6M)	(686.4M)
Short Term Debt	161.2M	340.0M	445.0M	231.2M	503.4M	528.6M
Intangible Assets	230.9M	236.7M	169.6M	89.7M	53.0M	50.4M
Common Stock	1.9M	1.9M	1.8M	1.8M	1.8M	2.5M
Property Plant Equipment	254.0M	231.1M	485.7M	379.1M	436.0M	238.5M
Short Term Investments	1.8M	8.8M	5.8M	5.4M	4.4M	4.2M
Net Tangible Assets	(116.2M)	(98.2M)	(3.5M)	52.2M	47.0M	44.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Genpact Limited is a strong investment it is important to analyze Genpact's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genpact's future performance. For an informed investment choice regarding Genpact Stock, refer to the following important reports:

How To Invest In Genpact

Details

Is Genpact Stock a good investment?

Details

What is Genpact's Net Worth?

Details

Largest Data Processing & Outsourced Services Companies

View

Largest Information Technology Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Genpact Stock analysis

When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.

	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges

Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.311

Dividend Share

0.55

Earnings Share

3.41

Revenue Per Share

24.552

Quarterly Revenue Growth

0.04

The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genpact Ebitda vs Other Operating Expenses Analysis

Ebitda vs Other Operating Expenses

Ebitda vs Other Operating Expenses Correlation Analysis

Correlation Coefficient

Ebitda

Other Operating Expenses

Genpact fundamental ratios Correlations

Genpact Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genpact fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Genpact Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 0.99	Total Assets
Short Long Term Debt Total	+ 0.99	Total Liab
Good Will	+ 0.99	Other Current Liab
Total Liab	+ 0.98	Total Assets
Other Current Liab	+ 0.98	Total Assets

Common Stock Total Equity	- 0.89	Other Stockholder Equity
Common Stock Total Equity	- 0.88	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.82	Total Current Assets
Common Stock Total Equity	- 0.8	Total Stockholder Equity
Common Stock Total Equity	- 0.79	Other Liab
Common Stock Total Equity	- 0.72	Cash And Short Term Investments